We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
Cap. Flow
+$235M
Cap. Flow %
3.1%
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$71M
2
BAX icon
Baxter International
BAX
+$60.7M
3
TMUS icon
T-Mobile US
TMUS
+$60.1M
4
PRGO icon
Perrigo
PRGO
+$53.7M
5
NRG icon
NRG Energy
NRG
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.11%
2 Industrials 11.84%
3 Consumer Discretionary 11.65%
4 Technology 10.61%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMUS icon
1
T-Mobile US
TMUS
$184B
$232M 3.06%
8,597,767
+2,175,864
+34% +$60.1M
ZTS icon
2
Zoetis
ZTS
$31.3B
$166M 2.19%
3,861,089
+56,173
+1% +$2.28M
AZO icon
3
AutoZone
AZO
$47.7B
$140M 1.84%
225,623
+43,929
+24% +$24.8M
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2B
$123M 1.63%
5,599,188
+430,848
+8% +$9.68M
MU icon
5
Micron Technology
MU
$1.12T
$110M 1.46%
3,154,121
-632,102
-17% -$20.9M
HPQ icon
6
HP
HPQ
$22.4B
$101M 1.34%
5,562,472
+855,188
+18% +$14.3M
AAL icon
7
American Airlines Group
AAL
$8.96B
$87.9M 1.16%
1,639,590
-436,400
-21% -$18.8M
PPG icon
8
PPG Industries
PPG
$25.4B
$87.8M 1.16%
759,502
+148,776
+24% +$15.4M
PFE icon
9
Pfizer
PFE
$143B
$87.3M 1.15%
2,953,253
+1,408,581
+91% +$40.4M
CMCSA icon
10
Comcast
CMCSA
$78.3B
$85.7M 1.13%
2,955,342
+262,796
+10% +$7.2M
COF icon
11
Capital One
COF
$123B
$82M 1.08%
992,961
+398,350
+67% +$32.4M
AGN
12
DELISTED
Allergan Inc
AGN
$79.1M 1.04%
372,011
+357,098
+2,395% +$71M
FDX icon
13
FedEx
FDX
$74.7B
$77.5M 1.02%
446,076
+79,756
+22% +$13.5M
PRGO icon
14
Perrigo
PRGO
$1.4B
$76.2M 1.01%
455,639
+343,186
+305% +$53.7M
MOS icon
15
The Mosaic Company
MOS
$7.08B
$75.1M 0.99%
1,644,884
+1,111,446
+208% +$49.3M
CP icon
16
Canadian Pacific Kansas City
CP
$82B
$69.5M 0.92%
1,803,955
+717,065
+66% +$28.4M
COO icon
17
Cooper Companies
COO
$13.7B
$69.1M 0.91%
1,705,152
-14,960
-0.9% -$600K
UNP icon
18
Union Pacific
UNP
$181B
$67.8M 0.9%
569,177
+142,299
+33% +$16.3M
LBTYK icon
19
Liberty Global Class C
LBTYK
$3.37B
$66.6M 0.88%
1,705,060
-947,488
-36% -$34.6M
C icon
20
Citigroup
C
$221B
$66.6M 0.88%
1,230,501
+322,235
+35% +$17.1M
BAX icon
21
Baxter International
BAX
$11.2B
$62M 0.82%
+1,557,838
New +$60.7M
MON
22
DELISTED
Monsanto Co
MON
$54.4M 0.72%
455,739
+253,584
+125% +$29.5M
HSY icon
23
Hershey
HSY
$34.9B
$53.7M 0.71%
516,346
+60,347
+13% +$5.88M
AMSG
24
DELISTED
Amsurg Corp
AMSG
$52.9M 0.7%
965,896
+792,242
+456% +$40.4M
PKG icon
25
Packaging Corp of America
PKG
$20.8B
$52.5M 0.69%
672,958
+353,851
+111% +$25.4M

Similar funds

Marshall Wace's Q4 2014 Portfolio in Review

As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.

  • Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
  • Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
  • Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
  • Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
  • Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
  • Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
  • Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.

Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.